What does CUSIP 40423R105 represent in this 13F holders report?

CUSIP 40423R105 is the security identifier for HCWB - HCW Biologics Inc. - COM used to aggregate holder disclosures.

How many institutions held HCWB - HCW Biologics Inc. - COM in Q4 2023?

18 institutional investors reported HCWB - HCW Biologics Inc. - COM for Q4 2023. Use the holders table for investor-level position and value details.

HCW Biologics Inc. - COM (HCWB)

CUSIP: 40423R105

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / COM
Total 13F shares: 1,064,955
Total 13F value: $1,300,606
Share change: +50,134
SEC-reported price per share: $1.22
Number of holders: 18
Value change: +$57,927
Number of buys: 11
Number of sells: 3

Security key

40423R105

Report period

Q4 2023

Institutions

Top holders

HCWB full security history Ownership snapshot Full 13F holder table HCW Biologics Inc. SEC filings HCW Biologics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HCWB - HCW Biologics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

HighTower Advisors, LLC

Disclosed value leader

HighTower Advisors, LLC

Comparable rows

0/15

Latest evidence

11 Dec 2023

13F 3/4/5 Highest disclosed value: $675,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

HighTower Advisors, LLC has the largest disclosed position value at $675K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HighTower Advisors, LLC's linked filing trail.

Disclosed position value Top 5

HighTower Advisors, LLC $675K

VANGUARD GROUP INC $388.8K

GEODE CAPITAL MANAGEMENT, LLC $253.2K

Cresset Asset Management, LLC $250.8K

Peter Rhode $161.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
HighTower Advisors, LLC	13F Company 13F	— class O/S missing	$675,000 354,869 shares	—	30 Sep 2023
VANGUARD GROUP INC	13F Company 13F	— class O/S missing	$388,776 204,619 shares	—	30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— class O/S missing	$253,171 132,503 shares	—	30 Sep 2023
Cresset Asset Management, LLC	13F Company 13F	— class O/S missing	$250,781 131,990 shares	—	30 Sep 2023
Peter Rhode	3/4/5 Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. 3/4/5	— mixed-class rows	$161,061 136,354 shares mixed-class rows	—	11 Dec 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F Company 13F	— class O/S missing	$157,766 82,600 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,064,955

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %